|
|
| (не показана 1 промежуточная версия этого же участника) |
| Строка 1: |
Строка 1: |
| − | One not unusual type of arthritis that has been relatively disregarded till recently is psoriatic arthritis. It's a systemic inflammatory destructive form of arthritis that is perhaps 2d best to rheumatoid arthritis in its ability to cause disability.
| + | Content removed |
| − | | |
| − | It is frequently described as a blended disease since in contrast to rheumatoid arthritis which is only a damaging breakdown disease that causes bone loss, joint erosions, and joint destruction, psoriatic arthritis (PA), also camakes use of new bone shapeation.
| |
| − | | |
| − | The sorts of systemic features that accompany this condition are also unique in that inflammatory bowel disease, eye inflammation (uveitis), and psoriasis generally tend to accompanew york this kind of arthritis.
| |
| − | | |
| − | Any other distinctive feature of the disease is the presence of enthesopathy, a localized inflammation at the site where the tendons attach to bone. Areas the place this repeatedly happens are the Achilles tendon, lateral epicondyle of the elbow, iliac crest, painformar tendon of the knee, plantar fascia of the heel, and the lateral hip.
| |
| − | | |
| − | In addition, PA incessantly items with a peculiar condition called dactylitis. This happens when the joints and tendon of a unmarried digit or a few digits change into acutely inflamed. This provideation is a hallmark of the disease.
| |
| − | | |
| − | Patients with PA also have co-morbid prerequisites that can affect the disease. Examples come with, hypertension, obesity, diabetes, elevated lipids, and heart disease.
| |
| − | | |
| − | Treatments for psoriatic arthritis are not nearly as agreed upon as those for rheumatoid arthritis.
| |
| − | | |
| − | Even as non-steroidal anti-inflammatory drugs (NSIADS) may be helpful for early symptomatic reduction, they are useless in regards to slowing disease progression.
| |
| − | | |
| − | 2nd line medicine, called disease-enhancing anti-rheumatic medication (DMARDS), at the same time as continuously utilized in a similar fashion to the way they're used in rheumatoid arthritis, are not nearly as effective. For example, the DMARD of choice in rheumatoid arthritis is methotrexate. Even as this drug works in a few cases of psoriatic arthritis, its results are not as are expectingable. Additionally, it appears that patients with this condition may be at more possibility for liver toxicity because of methotrexate.
| |
| − | | |
| − | Plaquenil, another DMARD that is used for RA, radepend is valuable for the disease.
| |
| − | | |
| − | Sulfasalazine (Azulfidine), has been used with a few good fortune but again, the results are not as expectable or dependable.
| |
| − | | |
| − | The only workforce of medicines that appears to paintings smartly for psoriatic arthritis in a predicable fashion are the TNF inhibitors. There's some debate that certain TNF inhibitors work better for the skin than others. That is the subject of endured investigation.
| |
| − | | |
| − | Different biologic treatments are in the pipeline.
| |
| − | | |
| − | [http://www.psoriasisdaily.com psoriasis info]
| |
